{"id":"W2151822189","doi":"10.1093/rheumatology/keh153","title":"Improvement in health utility among patients with rheumatoid arthritis treated with adalimumab (a human anti-TNF monoclonal antibody) plus methotrexate","year":2004,"lang":"en","type":"review","venue":"Lara D. Veeken","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"McMaster University; University of Ottawa; Abbott Laboratories","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Placebo; Infliximab; Internal medicine; Methotrexate; Population; Physical therapy; Health Utilities Index; Quality of life (healthcare); TNF inhibitor; Quality-adjusted life year; Surgery; Health related quality of life; Cost effectiveness; Tumor necrosis factor alpha; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002731451,0.0003629138,0.001484248,0.0003978105,0.0002604327,0.0005985593,0.0002505654,0.0006588456,0.0008124487],"category_scores_gemma":[0.002985073,0.0002392562,0.001249427,0.000445027,0.0004078503,0.0004167513,0.0002686016,0.0006357978,0.000107501],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004148135,"about_ca_system_score_gemma":0.0003893061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006086923,"about_ca_topic_score_gemma":0.0009687786,"domain_scores_codex":[0.9986507,0.0007605818,0.0001574324,0.0001351402,0.0001898655,0.0001063256],"domain_scores_gemma":[0.9984598,0.000692202,0.0004724504,0.00005103102,0.00008462236,0.0002399323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.5259162,0.009135596,0.3710918,0.001402949,0.008489029,0.0002534699,0.0003313685,0.001590589,0.01135839,0.0001170175,0.0005862725,0.06972732],"study_design_scores_gemma":[0.07403895,0.2143309,0.7019481,0.0001038319,0.004122608,0.0005122835,0.0001431933,0.001847495,0.001966374,0.0001296368,0.0008022773,0.00005426655],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9966449,0.00286133,0.00007290718,0.00004562546,0.00001373108,0.0000531913,0.00006633907,0.000003315859,0.0002385533],"genre_scores_gemma":[0.9992174,0.0003873833,0.0001198807,0.00006195092,0.00002479452,0.0000393468,0.00009418413,4.841091e-7,0.00005454974],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.002731451,"threshold_uncertainty_score":0.01444548,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02429936411162434,"score_gpt":0.3230364257934593,"score_spread":0.2987370616818349,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}